|
|
||||||||
Parasite genotyping by the polymerase chain reaction was used to distinguish recrudescent from newly acquired Plasmodium falciparum infections in a Karen population resident on the northwestern border of Thailand where malaria transmission is low (one infection/person/year). Plasmodium falciparum infections were genotyped for allelic variation in three polymorphic antigen loci, merozoite surface proteins-1 and -2 (MSP-1 and -2) and glutamaterich protein (GLURP), before and after antimalarial drug treatment. Population genotype frequencies were measured to provide the baseline information to calculate the probability of a new infection with a different or the same genotype to the initial pretreatment isolate. Overall, 38% of the infections detected following treatment had an identical genotype before and up to 121 days after treatment. These post-treatment genotypes were considered recrudescent because of the low (< 5%) probability of repeated occurrence by chance in the same patient. This approach allows studies of antimalarial drug treatment to be conducted in areas of low transmission since recrudescences can be distinguished confidently from newly acquired infections.
This article has been cited by other articles:
![]() |
S. Liu, J. Mu, H. Jiang, and X.-z. Su Effects of Plasmodium falciparum Mixed Infections on In Vitro Antimalarial Drug Tests and Genotyping Am J Trop Med Hyg, August 1, 2008; 79(2): 178 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tarning, E. A. Ashley, N. Lindegardh, K. Stepniewska, L. Phaiphun, N. P. J. Day, R. McGready, M. Ashton, F. Nosten, and N. J. White Population Pharmacokinetics of Piperaquine after Two Different Treatment Regimens with Dihydroartemisinin-Piperaquine in Patients with Plasmodium falciparum Malaria in Thailand Antimicrob. Agents Chemother., March 1, 2008; 52(3): 1052 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zhong, Y. Afrane, A. Githeko, Z. Yang, L. Cui, D. M. Menge, E. A. Temu, and G. Yan Plasmodium falciparum Genetic Diversity in Western Kenya Highlands Am J Trop Med Hyg, December 1, 2007; 77(6): 1043 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Price, A. R. Hasugian, A. Ratcliff, H. Siswantoro, H. L. E. Purba, E. Kenangalem, N. Lindegardh, P. Penttinen, F. Laihad, E. P. Ebsworth, et al. Clinical and Pharmacological Determinants of the Therapeutic Response to Dihydroartemisinin-Piperaquine for Drug-Resistant Malaria Antimicrob. Agents Chemother., November 1, 2007; 51(11): 4090 - 4097. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Greenhouse, C. Dokomajilar, A. Hubbard, P. J. Rosenthal, and G. Dorsey Impact of Transmission Intensity on the Accuracy of Genotyping To Distinguish Recrudescence from New Infection in Antimalarial Clinical Trials Antimicrob. Agents Chemother., September 1, 2007; 51(9): 3096 - 3103. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Ashley, K. Stepniewska, N. Lindegardh, R. McGready, R. Hutagalung, R. Hae, P. Singhasivanon, N. J. White, and F. Nosten Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria. Antimicrob. Agents Chemother., July 1, 2006; 50(7): 2281 - 2285. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. GUTHMANN, S. COHUET, C. RIGUTTO, F. FORTES, N. SARAIVA, J. KIGULI, J. KYOMUHENDO, M. FRANCIS, F. NOEL, M. MULEMBA, et al. High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in caala, central angola. Am J Trop Med Hyg, July 1, 2006; 75(1): 143 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. SLATER, M. KIGGUNDU, C. DOKOMAJILAR, M. R. KAMYA, N. BAKYAITA, A. TALISUNA, P. J. ROSENTHAL, and G. DORSEY DISTINGUISHING RECRUDESCENCES FROM NEW INFECTIONS IN ANTIMALARIAL CLINICAL TRIALS: MAJOR IMPACT OF INTERPRETATION OF GENOTYPING RESULTS ON ESTIMATES OF DRUG EFFICACY Am J Trop Med Hyg, August 1, 2005; 73(2): 256 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. NGRENNGARMLERT, J. J. KWIEK, D. D. KAMWENDO, K. RITOLA, R. SWANSTROM, C. WONGSRICHANALAI, R. S. MILLER, W. ITTARAT, and S. R. MESHNICK MEASURING ALLELIC HETEROGENEITY IN PLASMODIUM FALCIPARUM BY A HETERODUPLEX TRACKING ASSAY Am J Trop Med Hyg, June 1, 2005; 72(6): 694 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Stepniewska, W. R.J. Taylor, M. Mayxay, R. Price, F. Smithuis, J.-P. Guthmann, K. Barnes, H. Y. Myint, M. Adjuik, P. Olliaro, et al. In Vivo Assessment of Drug Efficacy against Plasmodium falciparum Malaria: Duration of Follow-Up Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4271 - 4280. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Talisuna, P. Bloland, and U. D'Alessandro History, Dynamics, and Public Health Importance of Malaria Parasite Resistance Clin. Microbiol. Rev., January 1, 2004; 17(1): 235 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. HAPPI, G. O. GBOTOSHO, A. SOWUNMI, C. O. FALADE, D. O. AKINBOYE, L. GERENA, D. E. KYLE, W. MILHOUS, D. F. WIRTH, and A. M. J. ODUOLA MOLECULAR ANALYSIS OF PLASMODIUM FALCIPARUM RECRUDESCENT MALARIA INFECTIONS IN CHILDREN TREATED WITH CHLOROQUINE IN NIGERIA Am J Trop Med Hyg, January 1, 2004; 70(1): 20 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. CHAORATTANAKAWEE, O. NATALANG, H. HANANANTACHAI, M. NACHER, A. BROCKMAN, S. KRUDSOOD, S. LOOAREESUWAN, and J. PATARAPOTIKUL STORAGE DURATION AND POLYMERASE CHAIN REACTION DETECTION OF PLASMODIUM FALCIPARUM FROM BLOOD SPOTS ON FILTER PAPER Am J Trop Med Hyg, July 1, 2003; 69(1): 42 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. SUPUTTAMONGKOL, S. CHINDARAT, S. SILPASAKORN, S. CHAIKACHONPATD, K. LIM, K. CHANTHAPAKAJEE, N. KAEWKAUKUL, and V. THAMLIKITKUL THE EFFICACY OF COMBINED MEFLOQUINE-ARTESUNATE VERSUS MEFLOQUINE-PRIMAQUINE ON SUBSEQUENT DEVELOPMENT OF PLASMODIUM FALCIPARUM GAMETOCYTEMIA Am J Trop Med Hyg, May 1, 2003; 68(5): 620 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. CATTAMANCHI, D. KYABAYINZE, A. HUBBARD, P. J. ROSENTHAL, and G. DORSEY DISTINGUISHING RECRUDESCENCE FROM REINFECTION IN A LONGITUDINAL ANTIMALARIAL DRUG EFFICACY STUDY: COMPARISON OF RESULTS BASED ON GENOTYPING OF MSP-1, MSP-2, AND GLURP Am J Trop Med Hyg, February 1, 2003; 68(2): 133 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. H. Branch, S. Takala, S. Kariuki, B. L. Nahlen, M. Kolczak, W. Hawley, and A. A. Lal Plasmodium falciparum Genotypes, Low Complexity of Infection, and Resistance to Subsequent Malaria in Participants in the Asembo Bay Cohort Project Infect. Immun., December 1, 2001; 69(12): 7783 - 7792. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ezzet, M. van Vugt, F. Nosten, S. Looareesuwan, and N. J. White Pharmacokinetics and Pharmacodynamics of Lumefantrine (Benflumetol) in Acute Falciparum Malaria Antimicrob. Agents Chemother., March 1, 2000; 44(3): 697 - 704. [Abstract] [Full Text] |
||||
![]() |
R. N. Price, C. Cassar, A. Brockman, M. Duraisingh, M. van Vugt, N. J. White, F. Nosten, and S. Krishna The pfmdr1 Gene Is Associated with a Multidrug-Resistant Phenotype in Plasmodium falciparum from the Western Border of Thailand Antimicrob. Agents Chemother., December 1, 1999; 43(12): 2943 - 2949. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |